Literature DB >> 23257401

Single nucleotide polymorphism of CD40 region and the risk of systemic lupus erythematosus.

P Piotrowski1, M Lianeri, M Wudarski, M Olesinska, P P Jagodzinski.   

Abstract

There is one study on the association of the CD40 G > T (rs4810485) single nucleotide polymorphism (SNP) as a risk factor of systemic lupus erythematosus (SLE). Therefore, we studied the prevalence of the CD40 G > T SNP in patients with SLE (n = 261) and controls (n = 545) in a Polish population. We did not find significant differences between the CD40 G > T genotype and allele frequency in patients with SLE and healthy individuals. However, the frequency of the CD40 TT and GT genotypes was statistically different between patients with arthritis and neurologic manifestations and patients without these symptoms (OR = 0.2009 (95% CI = 0.07547-0.5348, p = 0.0004, p (corr) = 0.0068) and OR = 0.2876 (95% CI = 0.1371-0.6031, p = 0.0005, p (corr) = 0.0085) respectively). Our observations indicate that the CD40 T variant might be negatively associated with some clinical disease manifestations in patients with SLE.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23257401     DOI: 10.1177/0961203312470184

Source DB:  PubMed          Journal:  Lupus        ISSN: 0961-2033            Impact factor:   2.911


  7 in total

1.  Gene-gene interaction between CD40 and CD226 gene on systemic lupus erythematosus in the Chinese Han population.

Authors:  Daqing Nie; Hongbo Li; Guixiu Yan; Zhengyi Wang; Zhaomin He; Wenyu Zhou
Journal:  Rheumatol Int       Date:  2016-10-08       Impact factor: 2.631

2.  Association of CD40 polymorphisms and haplotype with risk of systemic lupus erythematosus.

Authors:  Cheng-Jiang Wu; Jing Guo; Hong-Cheng Luo; Chuan-Dong Wei; Chun-Fang Wang; Yan Lan; Ye-Sheng Wei
Journal:  Rheumatol Int       Date:  2015-08-21       Impact factor: 2.631

3.  The association of CD40 polymorphism (rs1883832C/T) and soluble CD40 with the risk of systemic lupus erythematosus among Egyptian patients.

Authors:  Taghreed G Mousa; Hanan H Omar; Rasha Emad; Mona I Salama; Waleed Omar; Mohamed Fawzy; Howayda M Hassoba
Journal:  Clin Rheumatol       Date:  2018-10-29       Impact factor: 2.980

4.  The association of CD40 polymorphisms with CD40 serum levels and risk of systemic lupus erythematosus.

Authors:  Jian-Ming Chen; Jing Guo; Chuan-Dong Wei; Chun-Fang Wang; Hong-Cheng Luo; Ye-Sheng Wei; Yan Lan
Journal:  BMC Genet       Date:  2015-10-16       Impact factor: 2.797

5.  Single nucleotide polymorphisms in the CD40 gene associate with the disease susceptibility and severity in knee osteoarthritis in the Chinese Han population: a case-control study.

Authors:  Zhen-Han Deng; Ming-Hua Sun; Yu-Sheng Li; Wei Luo; Fang-Jie Zhang; Jian Tian; Ping Wu; Wen-Feng Xiao
Journal:  BMC Musculoskelet Disord       Date:  2017-03-21       Impact factor: 2.362

6.  Aberrant Expressions of Co-stimulatory and Co-inhibitory Molecules in Autoimmune Diseases.

Authors:  Weiwei He; Bin Wang; Qian Li; Qiuming Yao; Xi Jia; Ronghua Song; Sheli Li; Jin-An Zhang
Journal:  Front Immunol       Date:  2019-02-20       Impact factor: 7.561

7.  Association of soluble CD40 levels with -1 C > T CD40 polymorphism and chronic kidney disease in systemic lupus erythematosus.

Authors:  Raziel Tapia-Llanos; José F Muñoz-Valle; Ilce V Román-Fernández; Miguel Marín-Rosales; Diana C Salazar-Camarena; Alvaro Cruz; Gerardo Orozco-Barocio; Jorge A Guareña-Casillas; Edith Oregon-Romero; Claudia A Palafox-Sánchez
Journal:  Mol Genet Genomic Med       Date:  2019-10-23       Impact factor: 2.183

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.